Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota; and.
J Neurosurg. 2017 Jun;126(6):1764-1771. doi: 10.3171/2016.4.JNS152587. Epub 2016 Jul 1.
OBJECTIVE An increasing number of patients with poor-grade aneurysmal subarachnoid hemorrhage (aSAH) have received endovascular treatment. Endovascular treatment of poor-grade aSAH, however, is based on single-center retrospective studies, and predictors of long-term outcome have not been well defined. Using results from a multicenter prospective registry, the authors aimed to develop preoperative and postoperative prognostic models to predict poor outcome after endovascular treatment of poor-grade aSAH. METHODS A Multicenter Poor-grade Aneurysm Study (AMPAS) was a prospective and observational registry of consecutive patients with poor-grade aSAH. From October 2010 to March 2012, 366 patients were enrolled in the registry, and 136 patients receiving endovascular treatment were included in this study. Outcome was assessed by modified Rankin Scale (mRS) score at 12 months, and poor outcome was defined as an mRS score of 4, 5, or 6. Prognostic models were developed in multivariate logistic regression models. The area under receiver operating characteristic curves (AUC) was used to assess the model's discriminatory ability, and Hosmer-Lemeshow goodness-of-fit tests were used to assess the calibration. RESULTS At 12 months, 64 patients (47.0%) had a poor outcome: 9 (6.6%) had an mRS score of 4, 6 (4.4%) had an mRS score of 5, and 49 (36.0%) had died. Univariate analyses showed that older age (p = 0.001), female sex (p = 0.044), lower Glasgow Coma Scale score (p < 0.001), a World Federation of Neurosurgical Societies (WFNS) grade of V (p < 0.001), higher Fisher grade (p < 0.001), modified Fisher grade (p < 0.001), and wider neck aneurysm (p = 0.026) were associated with a poor outcome. There was a trend toward a worse outcome in patients with anterior communicating artery aneurysms (p = 0.080) and in those with incompletely occluded aneurysms (p = 0.063). After endovascular treatment, the presence of cerebral infarction (p = 0.039), symptomatic vasospasm (p = 0.039), and pneumonia (p = 0.006) were associated with a poor outcome. Multivariate analyses showed that the preoperative prognostic model including age, a WFNS grade of V, modified Fisher grade, and aneurysm neck size had excellent discrimination with an AUC of 0.86 (95% CI 0.80-0.92, p < 0.001), and a postoperative model that included these predictors as well as postoperative pneumonia had excellent discrimination (AUC = 0.87, 95% CI 0.81-0.93, p < 0.001). Both models had good calibration (p = 0.941 and p = 0.653, respectively). CONCLUSIONS Older age, WFNS Grade V, higher modified Fisher grade, wider neck aneurysm, and postoperative pneumonia were independent predictors of poor outcome after endovascular treatment of poor-grade aSAH. The preoperative model had almost the same discrimination as the postoperative model. Endovascular treatment should be carefully considered in patients with poor-grade aSAH with ruptured wide-neck aneurysms. ▪ CLASSIFICATION OF EVIDENCE Type of question: prognostic; study design: retrospective cohort trial; evidence: Class I.
越来越多的低分级动脉瘤性蛛网膜下腔出血(aSAH)患者接受了血管内治疗。然而,低分级 aSAH 的血管内治疗基于单中心回顾性研究,长期预后的预测因素尚未明确。本研究旨在使用多中心前瞻性登记资料,建立术前和术后预测模型,以预测低分级 aSAH 血管内治疗后的不良预后。
多中心低分级动脉瘤研究(AMPAS)是一项连续低分级 aSAH 患者的前瞻性观察性登记研究。2010 年 10 月至 2012 年 3 月,共纳入 366 例患者,其中 136 例行血管内治疗,纳入本研究。采用改良 Rankin 量表(mRS)评分评估 12 个月时的预后,mRS 评分 4、5、6 分定义为预后不良。采用多变量逻辑回归模型建立预测模型。使用受试者工作特征曲线下面积(AUC)评估模型的区分能力,Hosmer-Lemeshow 拟合优度检验评估模型的校准度。
12 个月时,64 例患者(47.0%)预后不良:9 例(6.6%)mRS 评分 4 分,6 例(4.4%)mRS 评分 5 分,49 例(36.0%)死亡。单因素分析显示,年龄较大(p=0.001)、女性(p=0.044)、格拉斯哥昏迷量表评分较低(p<0.001)、世界神经外科学会联合会(WFNS)分级为 V 级(p<0.001)、Fisher 分级较高(p<0.001)、改良 Fisher 分级较高(p<0.001)、动脉瘤颈较宽(p=0.026)与预后不良相关。前交通动脉瘤(p=0.080)和不完全闭塞动脉瘤(p=0.063)患者的预后较差。血管内治疗后,脑梗死(p=0.039)、症状性血管痉挛(p=0.039)和肺炎(p=0.006)与预后不良相关。多因素分析显示,包括年龄、WFNS 分级 V、改良 Fisher 分级和动脉瘤颈大小的术前预测模型具有优异的区分能力,AUC 为 0.86(95%CI 0.80-0.92,p<0.001),包括这些预测因素以及术后肺炎的术后预测模型具有优异的区分能力(AUC=0.87,95%CI 0.81-0.93,p<0.001)。两个模型均具有良好的校准度(p=0.941 和 p=0.653)。
年龄较大、WFNS 分级 V、改良 Fisher 分级较高、动脉瘤颈较宽和术后肺炎是低分级 aSAH 血管内治疗后不良预后的独立预测因素。术前模型与术后模型具有相似的区分能力。对于破裂宽颈动脉瘤的低分级 aSAH 患者,应慎重考虑血管内治疗。